| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Proteon Therapeutics Inc | 1,165,344 | 2,039,000 | 5.44% | ||
| 2 | ARGOS THERAPEUTICS INC | 5,120,604 | 2,314,000 | 6.17% | Call | |
| 3 | ARGOS THERAPEUTICS INC | 13,242,279 | 5,984,000 | 15.97% | ||
| 4 | Protagonist Therapeutics, Inc. | 982,270 | 12,583,000 | 33.57% | ||
| 5 | JOUNCE THERAPEUTICS INC | 662,063 | 14,559,000 | 38.85% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0000950123-17-008128, filed 2017.08.17).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
